Evaluation and Control of WAG in PACU Within Patient and Caregiver Breathing Zone

October 12, 2016 updated by: Teleflex

Evaluation and Control of Waste Anesthetic Gas (WAG) in the Post Anesthesia Care Unit (PACU) Within Patient and Caregiver Breathing Zone

The purpose of this study is to evaluate anesthetic gas in the PACU within patient and caregiver breathing zones.

Study Overview

Detailed Description

The purpose of this single-center, multi-arm, randomized controlled study is to evaluate use of the ISO-Gard mask in patients immediately following a surgical procedure in which inhaled anesthetic is used as the primary modality of anesthesia, for the following: 1) measure the waste anesthetic gas emanating from patient during the immediate one hour post-operative recovery period in the PACU; 2) measure waste anesthetic gas within PACU caregiver's breathing zone; and 3) determine the efficacy of the ISO-Gard mask in reducing caregiver's exposure to waste anesthetic gas in the PACU.

Subjects who will receive either Sevoflurane or Desflurane inhaled anesthetic will be enrolled in this study. Subjects will be randomized to receive either the ISO-Gard scavenging mask or a traditional supplemental oxygen mask post operatively; all other elements of the subjects' care will be in accordance with the institution's standard of care.

Study Type

Interventional

Enrollment (Actual)

125

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Subject is 18-120 years of age.
  • Patients requiring inhaled anesthetic agents as part of their anesthesia during surgery (Sevoflurane or Desflurane)
  • Patients with following outpatient procedures scheduled for a duration of greater than 2 hours per the operating room schedule:

    1. . Bariatric procedures
    2. Robotic surgery cases
    3. Orthopedic
    4. Gynecological procedures
    5. ENT
    6. Plastic
  • Not documented as terminally ill
  • Subject expected to remain in PACU for at least one hour
  • Subject or legally authorized representative has provided written informed consent prior to the procedure using a form that is approved by the Institutional Review Board (IRB).

Exclusion Criteria:

  • Patients are/were given/planned to be given total IV anesthetics during surgery
  • Any patient that is not expected to tolerate a mask in PACU
  • Subject has already been enrolled in study
  • Subject is an employee of the Investigator or has involvement in other studies under the direction of investigator or study site
  • Women who are pregnant
  • End of anesthetic gas administration in PACU bay greater than 45 minutes

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: Standard oxygen mask
Standard face mask to provide supplemental oxygen
Provide supplemental oxygen
ACTIVE_COMPARATOR: ISO-Gard Mask
Face mask to scavenge waste anesthetic gases from patient during recovery from general anesthesia and to provide supplemental oxygen.
to scavenge waste anesthetic gases from patients and provide supplemental oxygen

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Waste Anesthetic Gas Measured by Parts Per Million Within PACU Caregiver's Breathing Zone With Caring for Patients
Time Frame: 1 hour post-operative recovery period
The measurement of Waste Anesthetic Gas in parts per million resolution emanating from the patient to the caregiver's breathing zone.
1 hour post-operative recovery period
Waste Anesthetic Gas Measured by Parts Per Million Emanating From Patients During Normal PACU Working Conditions
Time Frame: 1 hour post-operative recovery period
The measurement of Waste Anesthetic Gas in parts per million emanating from the patient between the standard oxygen mask and the ISO-Gard oxygen mask.
1 hour post-operative recovery period
Efficacy of the ISO-Gard Mask in Reducing Caregiver's Exposure to WAG-Percentage of Time
Time Frame: 1 hour post-operative recovery period
For MAX-WAG measurements obtained every 30 seconds, we calculated the percentage of time in MAX-WAG [>2ppm] relative to the total collection period.
1 hour post-operative recovery period
Efficacy of the ISO-Gard Mask in Reducing Caregiver's Exposure to WAG-Duration
Time Frame: 1 hour post-operative recovery period
For MAX-WAG measurements obtained every 30 seconds, we calculated the duration of MAX-WAG [>2ppm]
1 hour post-operative recovery period

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: George W Williams III, MD, U of Texas Medical school at Houston

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2015

Primary Completion (ACTUAL)

November 1, 2015

Study Completion (ACTUAL)

December 1, 2015

Study Registration Dates

First Submitted

April 16, 2015

First Submitted That Met QC Criteria

April 22, 2015

First Posted (ESTIMATE)

April 28, 2015

Study Record Updates

Last Update Posted (ESTIMATE)

November 25, 2016

Last Update Submitted That Met QC Criteria

October 12, 2016

Last Verified

August 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • 2015-05 (APHM)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

The aggregate study results will be reported collectively, not individually by participant.

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Standard oxygen mask

Subscribe